Using Network Pharmacology to Systematically Decipher the Potential Mechanisms of Jisuikang in the Treatment of Spinal Cord Injury
Open Access
- 27 February 2022
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-14
Abstract
Objective. To identify the potential pharmacological targets of Jisuikang (JSK) for the treatment of spinal cord injury (SCI) using network pharmacology. Methods. The bioactive compounds of JSK herbs and their corresponding potential SCI targets were obtained from three traditional Chinese medicine (TCM) databases. SCI-related therapeutic target genes were obtained from the Comparative Toxicogenomics Database and the GeneCards Database. The common target genes between the JSK compounds and SCI-related therapeutic targets were screened using GO/KEGG functional enrichment and protein-protein interaction (PPI) analyses to identify hub genes and their categories of biological function. Gene expression distribution and receiver operating characteristic curve (ROC) analyses were used to identify probable SCI-related target genes. Molecular docking was used to quantify molecular interactions between target genes and the bioactive compounds of JSK. Results. A total of 183 JSK bioactive compounds and 197 target genes for the treatment of SCI were screened and assessed. The target genes were enriched primarily in drug metabolism and in inflammation-related biological processes. Ten genes with statistical significance were identified as therapeutic SCI-related target genes of JSK. Molecular docking experiments demonstrated that the proteins of these 10 genes docked with binding energies of less than 5kcal/mol with the bioactive compounds in JSK. Conclusion. This study showed that the anti-SCI effects of JSK may be mediated through numerous bioactive components, multiple gene targets, and inflammation-related pathways and provided potential novel targets for directed therapies for treating SCI. These results provide a foundation for further experimental investigations into treatment options for SCI.Keywords
Funding Information
- Science and Technology Development Program of TCM of Jiangsu Province (YB2020042, SKJJZD19)
- Wuxi Municipal Bureau on Science and Technology (YB2020042, SKJJZD19)
This publication has 52 references indexed in Scilit:
- CytoNCA: A cytoscape plugin for centrality analysis and evaluation of protein interaction networksBioSystems, 2015
- STRING v10: protein–protein interaction networks, integrated over the tree of lifeNucleic Acids Research, 2014
- TCMSP: a database of systems pharmacology for drug discovery from herbal medicinesJournal of Cheminformatics, 2014
- VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in RBMC Bioinformatics, 2011
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene listsNucleic Acids Research, 2008
- Network pharmacology: the next paradigm in drug discoveryNature Chemical Biology, 2008
- Effect of Jisuikang (???) on kinetic dysfunction in patients after spinal injuryChinese Journal of Integrative Medicine, 2008
- Evidence for the Role of Mitogen-Activated Protein Kinase Signaling Pathways in the Development of Spinal Cord InjuryThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003